NLRP3 and renal cell carcinoma: Collectively, these results revealed that BRD4 inhibition-elicited repression of EMT progression and proliferation and inducement of pyroptosis in RCC cells were mediated by NLRP3, and that NLRP3 might function as a tumor suppressor.